Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

New polypill increases adherence to treatment following myocardial infarction

A new polypill increases adherence to treatment following a myocardial infarction (MI), according to results from the FOCUS Study presented for the first time at ESC Congress 2014 today by principal investigator Dr Valentin Fuster, director of Mount Sinai Heart in New York, US.

1 Sep 2014

Researchers reveal transmission rate of MERS coronavirus

The MERS coronavirus has caused disease outbreaks across the Arabian Peninsula and spread to Europe several times. The severe pneumonia virus has claimed the lives of several hundred people since its discovery in 2012.

29 Aug 2014

CHEST issues new expert guidance while global health-care community cares for Ebola patients

The American College of Chest Physicians announces the immediate release of Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement today in the Online First section of the journal CHEST while the global health-care community cares for patients with the Ebola virus.

22 Aug 2014

Study identifies protein that appears to play key role in protecting people infected with tuberculosis

UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from developing the active form of the disease.

21 Aug 2014

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

18 Aug 2014

Viewpoints: Robin Williams' 'wakeup call'; surprise in Medicaid growth; tools to stop Ebola in U.S.

Earlier this year, [Robin] Williams checked himself into a rehabilitation facility. And whether he needed help with addiction or mental illness - or, as is so often the case, with both - it's safe to assume he got it. He had the money to afford the best and the sad truth is that, in some cases, even the best isn't enough to save people.

13 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

BD reports 5.1% increase in third fiscal quarter revenues

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014, representing an increase of 5.1 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 31 Jul 2014

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Medicare got some good news Monday, when the trustees who oversee its finances announced that the fund that pays for hospital care will remain solvent until 2030, four years longer than its forecast from last year.

30 Jul 2014

Sinovac selected to supply seasonal influenza vaccine to Beijing citizens

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014.

23 Jul 2014

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach’

23 Jul 2014

Lancet report: Support sex workers to prevent HIV

Across the world, in high- and low-income countries, women, men, and transgender people who sell sex are subjected to repressive and discriminatory law, policy, and practice, which in turn fuel human rights violations against them, including violence and discrimination. All of these factors are preventing sex workers from accessing the services which they need in order to effectively prevent and treat HIV infection, according to a major new Series on HIV and sex workers, published in The Lancet.

23 Jul 2014

EGPAF experts to deliver presentations at AIDS 2014

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations, moderate conference events, and exhibit a variety of educational posters and abstracts related to ending AIDS in children.

21 Jul 2014

Research roundup: Clinics and electronic records; young adults baffled by exchange; Medicare spending slowdown

We found that in 2012 nine out of ten health centers had adopted a EHR system, and half had adopted EHRs with basic capabilities. Seven in ten health centers reported that their providers were receiving meaningful-use incentive payments from the Centers for Medicare and Medicaid Services (CMS).

14 Jul 2014

Patient choice and hospital capacity during pandemic

Allowing patients to choose which hospital they attend when suffering illness during a pandemic rather than assigning them to a specific healthcare facility is appealing to patients during such a crisis. However, such a patient-centric hospital capacity management is conventionally viewed as inefficient system-wide.

8 Jul 2014

Growth hormone deficiency may protect people from developing Type 2 diabetes, cancer

People who lack growth hormone (GH) receptors also appear to have marked insulin sensitivity that prevents them from developing diabetes and lowers their risk for cancer, despite their increased percentage of body fat, new research finds.

24 Jun 2014

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Younger and older women tend to lose lean muscle mass, along with fat, unless they engage in physical activity before they attempt weight loss, a new study from Israel finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

24 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

Pandemic News and Research

Further Reading

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

New polypill increases adherence to treatment following myocardial infarction

Researchers reveal transmission rate of MERS coronavirus

CHEST issues new expert guidance while global health-care community cares for Ebola patients

Study identifies protein that appears to play key role in protecting people infected with tuberculosis

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Viewpoints: Robin Williams' 'wakeup call'; surprise in Medicaid growth; tools to stop Ebola in U.S.

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

BD reports 5.1% increase in third fiscal quarter revenues

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Sinovac selected to supply seasonal influenza vaccine to Beijing citizens

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Lancet report: Support sex workers to prevent HIV

EGPAF experts to deliver presentations at AIDS 2014

Research roundup: Clinics and electronic records; young adults baffled by exchange; Medicare spending slowdown

Patient choice and hospital capacity during pandemic

Growth hormone deficiency may protect people from developing Type 2 diabetes, cancer

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News